Valsartan NEW
| Price | $46 | $81 | $108 |
| Package | 10mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Valsartan | CAS No.: 137862-53-4 |
| Purity: 99.76% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Valsartan |
| Description | Valsartan (CGP 48933) is a tetrazole derivative and angiotensin II type 1 receptor blocker that is used to treat hypertension. |
| In vitro | Valsartan is a potent diuretic, ACE inhibitor, calcium antagonist, and β-blocker.Valsartan dose-dependently inhibited vasoconstriction of angiotensin II-induced vasoconstriction and lowered blood pressure in a renin-dependent model of hypertension. |
| In vivo | Valsartan is a potent diuretic, ACE inhibitor, calcium antagonist, and β-blocker.Valsartan dose-dependently inhibited vasoconstriction of angiotensin II-induced vasoconstriction and lowered blood pressure in a renin-dependent model of hypertension. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : < 10 mg/mL (22.96 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+90% Corn Oil : 2 mg/mL (4.59 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (22.96 mM), Solution. H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 250 mg/mL (574.03 mM), Sonication is recommended. |
| Keywords | Valsartan | TLR2 | proinflammatory | pressure | Inhibitor | inhibit | heart | failure | endothelial | cytokines | CGP-48933 | CGP48933 | blood | aorta | Angiotensin Receptor | angiotensin II receptor |
| Inhibitors Related | Losartan potassium | Tranilast | Enalapril Maleate | Telmisartan | Lisinopril dihydrate | Sacubitril/Valsartan | Benzyl benzoate | Irbesartan | Losartan | Ramipril | Diisononyl phthalate | Captopril |
| Related Compound Libraries | Bioactive Compound Library | Pediatric Drug Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Toxic Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Metabolism Disease Compound Library | NMPA-Approved Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $999.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-07-02 | |
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-02 | ||
| $1.00 |
VIP7Y
|
Jinan Jianfeng Chemical Co., Ltd
|
2026-07-02 | |
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-02 | ||
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-07-02 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-02 | ||
| $50.00 |
VIP5Y
|
Hebei Dangtong Import and export Co LTD
|
2026-07-01 | |
|
VIP3Y
|
Hangzhou Hyper Chemicals Limited
|
2026-05-29 | ||
| $121.00 |
VIP6Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2026-05-15 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY